XTL Biopharma raises capital $3.5 million through institutional investors March 19, 2012 CenterWatch Staff
Academic-industry collaboration seeks new drugs, treatments for autism March 19, 2012 CenterWatch Staff
Repligen enrolls first patient in phase I trial of Friedreich’s Ataxia March 19, 2012 CenterWatch Staff